Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.

Splicing factor gene mutations are the most frequent mutations found in patients with the myeloid malignancy myelodysplastic syndrome (MDS), suggesting that spliceosomal dysfunction plays a major role in disease pathogenesis. The aberrantly spliced target genes and deregulated cellular pathways asso...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Pellagatti, A, Boultwood, J
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Elsevier 2016

Gelijkaardige items

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
door: Armstrong, R, et al.
Gepubliceerd in: (2017)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
door: Boultwood, J, et al.
Gepubliceerd in: (2014)

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
door: Pellagatti, A, et al.
Gepubliceerd in: (2017)

Gene expression profiling in the myelodysplastic syndromes.
door: Pellagatti, A, et al.
Gepubliceerd in: (2005)

Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations
door: Johanna Flach, et al.
Gepubliceerd in: (2020-09-01)

SF3B1 mutant myelodysplastic syndrome: Recent advances
door: Pellagatti, A, et al.
Gepubliceerd in: (2020)

Lack of splice factor and cohesin complex mutations in pediatric myelodysplastic syndrome
door: Julia C. Obenauer, et al.
Gepubliceerd in: (2016-12-01)

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.
door: Yip, B, et al.
Gepubliceerd in: (2017)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
door: Boultwood, J, et al.
Gepubliceerd in: (2009)

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE IN MYELODYSPLASTIC SYNDROMES - REPLY
door: Boultwood, J, et al.
Gepubliceerd in: (1991)

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.
door: Pellagatti, A, et al.
Gepubliceerd in: (2003)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.
door: Fernandez-Mercado, M, et al.
Gepubliceerd in: (2013)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
door: Fernandez-Mercado, M, et al.
Gepubliceerd in: (2013)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
door: Fernandez-Mercado, M, et al.
Gepubliceerd in: (2010)

Clonality in the myelodysplastic syndromes.
door: Boultwood, J, et al.
Gepubliceerd in: (2001)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
door: Fernandez-Mercado, M, et al.
Gepubliceerd in: (2013)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
door: Boultwood, J, et al.
Gepubliceerd in: (2010)

The impact of spliceosome mutations in MDS
door: Jacqueline Boultwood, et al.
Gepubliceerd in: (2019-06-01)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes
door: Marta Fernandez-Mercado, et al.
Gepubliceerd in: (2013-12-01)

A novel splicing mutation in the gene encoding the chromatin-associated factor ATRX associated with acquired hemoglobin H disease in myelodysplastic syndrome (ATMDS)
door: Steensma, D, et al.
Gepubliceerd in: (2004)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
door: Pellagatti, A, et al.
Gepubliceerd in: (2008)

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1 mutant myelodysplastic syndromes
door: Dolatshad, H, et al.
Gepubliceerd in: (2016)

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
door: Bernard, E, et al.
Gepubliceerd in: (2020)

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation
door: Liberante, F, et al.
Gepubliceerd in: (2013)

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation.
door: Liberante, F, et al.
Gepubliceerd in: (2013)

Molecular pathogenesis of the myelodysplastic syndromes
door: Boultwood, J, et al.
Gepubliceerd in: (1999)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
door: Pellagatti, A, et al.
Gepubliceerd in: (2009)

Discovering transcription and splicing networks in myelodysplastic syndromes.
door: Hongyan Wang, et al.
Gepubliceerd in: (2013-01-01)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
door: Pellagatti, A, et al.
Gepubliceerd in: (2010)

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
door: Watkins, F, et al.
Gepubliceerd in: (2004)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
door: Pellagatti, A, et al.
Gepubliceerd in: (2014)

Telomere length in myelodysplastic syndromes.
door: Boultwood, J, et al.
Gepubliceerd in: (1995)

Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
door: Boultwood, J
Gepubliceerd in: (2009)

Structure of the granulocyte macrophage colony-stimulating factor gene in patients with the myelodysplastic syndromes.
door: Boultwood, J, et al.
Gepubliceerd in: (1990)

Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1
door: Iva Trsova, et al.
Gepubliceerd in: (2023-12-01)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
door: Pellagatti, A, et al.
Gepubliceerd in: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
door: Pellagatti, A, et al.
Gepubliceerd in: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
door: Pellagatti, A, et al.
Gepubliceerd in: (2010)

8 Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
door: Boultwood, J
Gepubliceerd in: (2009)

Neutrophil PRV-1 gene expression in myeloproliferative, myelodysplastic and reactive blood disorders
door: Zhang, J, et al.
Gepubliceerd in: (2004)